Interpretable Machine Learning for Predicting Symptomatic Pneumonitis in Locally Advanced Non -Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Immune Checkpoint Inhibitor Consolidation

被引：0
|
作者：
Duan, L. [1 ]
Lee, S. H. [1 ]
Yegya-Raman, N. [1 ]
Wang, D. [1 ]
Li, B. [1 ]
Friedes, C. [1 ]
Iocolano, M. [1 ]
Kao, G. D. [1 ]
Fan, Y. [1 ]
Caruana, R. [2 ]
Feigenberg, S. J. [1 ]
Xiao, Y. [1 ]
机构：
[1] Univ Penn, Dept Radiat Oncol, Philadelphia, PA USA
[2] Microsoft Res, Redmond, WA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3010
引用
收藏
页码：E464 / E464
页数：1
相关论文
共 50 条
  • [31] Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer
    H Katayama
    H Ueoka
    K Kiura
    M Tabata
    T Kozuki
    M Tanimoto
    T Fujiwara
    N Tanaka
    H Date
    M Aoe
    N Shimizu
    M Takemoto
    Y Hiraki
    British Journal of Cancer, 2004, 90 : 979 - 984
  • [32] Concurrent Chemoradiotherapy with Biweekly Gemcitabine and Cisplatin in Patients with Locally Advanced Non-small Cell Lung Cancer
    Oak, Chul Ho
    Kim, Ja Kyung
    La Jang, Lee
    Moon, Dae Sung
    Jang, Tae Won
    Jung, Maan Hong
    Cho, Sung Whan
    Jeung, Tae Sig
    RADIATION ONCOLOGY JOURNAL, 2008, 26 (03): : 160 - 165
  • [33] Concurrent chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer
    Song, X
    Gallant, V
    Laurie, S
    Nicholas, G
    Reaume, N
    MacRae, R
    Agboola, O
    Perry, G
    Lochrin, C
    Goss, G
    LUNG CANCER, 2005, 49 : S174 - S175
  • [34] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Xiaoyang Zhai
    Jian Zhang
    Yaru Tian
    Ji Li
    Wang Jing
    Hongbo Guo
    Hui Zhu
    Cancer Biology & Medicine, 2020, 17 (03) : 599 - 611
  • [35] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Zhai, Xiaoyang
    Zhang, Jian
    Tian, Yaru
    Li, Ji
    Jing, Wang
    Guo, Hongbo
    Zhu, Hui
    CANCER BIOLOGY & MEDICINE, 2020, 17 (03) : 599 - 611
  • [36] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Xiaoyang Zhai
    Jian Zhang
    Yaru Tian
    Ji Li
    Wang Jing
    Hongbo Guo
    Hui Zhu
    Cancer Biology & Medicine , 2020, (03) : 599 - 611
  • [37] Blood-based biomarker analysis for predicting efficacy of definitive concurrent chemoradiotherapy and durvalumab consolidation in patients with unresectable locally advanced non-small cell lung cancer
    Park, Cheol-Kyu
    Park, Hwa-Kyung
    Oh, Hyung-Joo
    Cho, Hyun-Ju
    Oh, In-Jae
    Kim, Young-Chul
    CANCER RESEARCH, 2022, 82 (12)
  • [38] Blood-based biomarker analysis for predicting efficacy of definitive concurrent chemoradiotherapy and durvalumab consolidation in patients with unresectable locally advanced non-small cell lung cancer
    Park, C-K.
    Cho, H-J.
    Oh, I-J.
    Kim, Y-C.
    ANNALS OF ONCOLOGY, 2021, 32 : S1379 - S1379
  • [39] Factors predicting radiation pneumonitis in locally advanced non-small cell lung cancer
    Kim, Myungsoo
    Lee, Jihae
    Ha, Boram
    Lee, Rena
    Lee, Kyung-Ja
    Suh, Hyun Suk
    RADIATION ONCOLOGY JOURNAL, 2011, 29 (03): : 181 - 190
  • [40] A Pilot Trial of Consolidation Bevacizumab after HypoFractionated Concurrent Chemoradiotherapy in Patients with Unresectable Locally Advanced Non-Squamous Non Small -Cell Lung Cancer
    Huo, L.
    Chu, C.
    Jiang, X.
    Zheng, S.
    Zhang, P.
    Zhou, R.
    Chen, N.
    Guo, J.
    Qiu, B.
    Liu, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E38 - E38
12345